Moderna Receives U.S. FDA Approval for RSV Vaccine mRESVIA(R)
Go back to Moderna Receives U.S. FDA Approval for RSV Vaccine mRESVIA(R)| Marina Biotech, Inc. (NASDAQ: MRNA) | Delayed: 135.20 -9.93 (6.84%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $145.13 | 52 Week High | $0.52 | |||
| Open | $142.70 | 52 Week Low | $0.08 | |||
| Day High | $145.50 | P/E | N/A | |||
| Day Low | $130.00 | EPS | $-3.80 | |||
| Volume | 13,299,334 | |||||
